se of IABP to reduce mortality in extensive myocardial infarction with persistent ischemia.

Completed

• Conditions: myocardial infarction; heart attack; 10028593

• Registration Number: NL-OMON42015
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

- Age 18 * 80 years old
- Acute ST-segment elevation myocardial infarction with summed ST-segment deviation *15 mm.
- Insufficient ST-segment resolution (<50%) on the ECG made 10-30 minutes after the primary PCI in the catheterization laboratory.

Exclusion Criteria

- Initial summed ST-segment deviation less than 15 mm
- ST-segment resolution *50% on the ECG performed in the catheterization laboratory
- Chest pain onset >8 hours before arrival
- Severe aortic valve stenosis/regurgitation
- Aortic abnormalities prohibitive for use of intra aortic balloon pump
- Full blown cardiogenic shock with immediate requirement of left ventricular assist device as judged necessary by the operator
- Inability to provide informed consent
- Pregnancy
- Inability to perform coronary angiography by the femoral approach

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Mortality, development of heart failure within six months necessitating<br /><br>hospital admission, and necessity for mechanical hemodynamic support</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None.</p><br>